FibrinogenCardiovascular DiseasesRisk FactorsAfibrinogenemiaFibrin Fibrinogen Degradation ProductsFibrinFibrinopeptide BBiological MarkersFibrinopeptide ABlood PlateletsHypertensionC-Reactive ProteinCohort StudiesAtherosclerosisPlatelet AggregationBlood CoagulationProspective StudiesPlatelet Membrane GlycoproteinsBlood PressureRisk AssessmentThrombinMetabolic Syndrome XCross-Sectional StudiesFollow-Up StudiesObesityFibrinolysisThrombin TimeReceptors, FibrinogenHemostasisDiabetes Mellitus, Type 2Diabetes MellitusPlatelet Glycoprotein GPIIb-IIIa ComplexBlood Coagulation DisordersBody Mass IndexPrevalenceLipidsCoronary DiseaseInflammationSmokingCholesterolProportional Hazards ModelsDyslipidemiasCholesterol, HDLIncidenceHomocysteineSex FactorsCholesterol, LDLFibrinolysinLife StyleBlood Coagulation TestsTime FactorsAge FactorsPlatelet AdhesivenessStrokeCause of DeathPlatelet ActivationUnited StatesEndothelium, VascularTriglyceridesRiskDiabetic AngiopathiesDiabetes ComplicationsMyocardial InfarctionDietPrimary PreventionThrombosisFactor XIIIAncrodHyperlipidemiasArteriosclerosisBlood GlucoseClot RetractionKidney Failure, ChronicCardiovascular SystemBatroxobinPredictive Value of TestsFactor VIIJapanBlood ViscosityHypercholesterolemiaHypolipidemic AgentsCoronary Artery DiseaseCase-Control StudiesMultivariate AnalysisRegression AnalysisAdenosine Diphosphatevon Willebrand FactorProthrombin TimeHydroxymethylglutaryl-CoA Reductase InhibitorsBlood Coagulation FactorsCalcinosisVascular DiseasesEuropean Continental Ancestry GroupInsulin ResistanceLinear ModelsCarotid ArteriesComorbidityLongitudinal StudiesSex DistributionOxidative Stress